TORONTO - Crystallex International Corporation (AMEX: KRY)(TSX: KRY) announced today that it has closed its previously announced equity financing for gross proceeds of Cdn$100 million. A syndicate of underwriters purchased 25 million common shares of Crystallex at a price of Cdn$4.00 per share. Crystallex has granted the underwriters an option to purchase up to an additional 3,750,000 common shares at the offering price for a period of 30 days from the closing of the financing.

Crystallex plans to use the net proceeds from the financing to fund development costs at the Las Cristinas Project in Venezuela.

This press release is not an offer to sell or the solicitation of an offer to buy the common shares, nor shall there be any sale of the common shares in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The common shares being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such common shares may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.

CONTACT:     VP Investor Relations: A. Richard Marshall   (800)-738-1577  
                          info@crystallex.com
                          www.crystallex.com